| Group A (993 patients) n (%) | Group B (1041 patients) n (%) | p value |  |
---|---|---|---|---|
Recurrent nerve palsy | 28 (2.82%) | 23 (2.21%) | 0.4604 | p > 0.05 |
• Unilateral | 26 (2.62%) | 21 (2.02%) | 0.4507 | p > 0.05 |
• Bilateral | 2 (0.2%) | 2 (0.19%) | 0.6503 | p > 0.05 |
Transient nerve palsy | 21 (2.11%) | 17 (1.63%) | 0.5232 | p > 0.05 |
• Total thyroidectomy | 15 (1.51%) | 12 (1.15%) | 0.6094 | p > 0.05 |
• Completion thyroidectomy | 2** (0.2%) | 2 (0.19%) | 0.583 | p > 0.05 |
• Total thyroidectomy + lymphectomy | 4 (0.4%) | 3 (0.29%) | 0.6981 | p > 0.05 |
• Multinodular goiter | 7 (0.7%) | 8 (0.77%) | 0.9875 | p > 0.05 |
• Differentiated carcinoma | 8** (0.81%) | 4 (0.38%) | 0.2569 | p > 0.05 |
• Hashimoto’s thyroiditis | 2 (0.2%) | 4 (0.38%) | 0.647 | p > 0.05 |
• Graves’ disease | 2 (0.2%) | 1 (0.1%) | 0.9546 | p > 0.05 |
• Medullary carcinoma | 0 | 0 | - | - |
Permanent nerve palsy | 7 (0.7%) | 6 (0.58%) | 0.9319 | p > 0.05 |
• Total thyroidectomy | 5* (0.5%) | 5* (0.48%) | 0.8081 | p > 0.05 |
• Completion thyroidectomy | 1 (0.1%) | 0 | 0.5792 | p > 0.05 |
• Total thyroidectomy + lymphectomy | 1 (0.1%) | 1 (0.1%) | 0.6082 | p > 0.05 |
• Multinodular goiter | 2* (0.2%) | 3 (0.29%) | 0.9928 | p > 0.05 |
• Differentiated carcinoma | 3 (0.3%) | 2* (0.19%) | 0.8691 | p > 0.05 |
• Hashimoto’s thyroiditis | 1 (0.1%) | 1 (0.1%) | 0.4951 | p > 0.05 |
• Graves’ disease | 1 (0.1%) | 0 | 0.974 | p > 0.05 |
• Medullary carcinoma | 0 | 0 | - | - |